Archive | The NeuroCircuit

Weekly Signal: 58 | Capital Picks the Smaller Footprint

Meta's NeuralBench lands; NEO goes commercial

Ricardo Albornoz

Neurotechnology

Weekly Signal: 57 | Three Strategic Bets Emerge in Neurotech

May 9, 2026

•

2 min read

Weekly Signal: 57 | Three Strategic Bets Emerge in Neurotech

Neuralink, SetPoint, ARIA each bet differently

Ricardo Albornoz

Weekly Signal: 56 | Trading Precision for Deployability in Neurotech

May 2, 2026

•

5 min read

Weekly Signal: 56 | Trading Precision for Deployability in Neurotech

Plus: depression implant clears FDA

Ricardo Albornoz

Clinical Trial News

Weekly Signal: 55 | CorTec Enters FDA's TAP for Chronic BCIs

Apr 25, 2026

•

2 min read

Weekly Signal: 55 | CorTec Enters FDA's TAP for Chronic BCIs

Plus €40.6M and a stealth exit

Ricardo Albornoz

Neurotechnology

Weekly Signal: 54 | Biohybrid BCI Hits Yale, Cala Clears

Apr 18, 2026

•

2 min read

Weekly Signal: 54 | Biohybrid BCI Hits Yale, Cala Clears

Invasiveness tiers get crowded

Ricardo Albornoz

Closed-loop DBS

Weekly Signal: 53 | CorTec Closes the BCI Loop

Apr 11, 2026

•

8 min read

Weekly Signal: 53 | CorTec Closes the BCI Loop

Plus: organoids go to war

Ricardo Albornoz

Closed-loop DBS

Weekly Signal: 52 | The Signal Everyone Used Was Wrong

Apr 4, 2026

•

9 min read

Weekly Signal: 52 | The Signal Everyone Used Was Wrong

Plus: living-neuron BCIs get a surgeon

Ricardo Albornoz

Neurotechnology

Weekly Signal: 51 | When the Brain Overcorrects

Mar 28, 2026

•

6 min read

Weekly Signal: 51 | When the Brain Overcorrects

Control, not just signal

Ricardo Albornoz

Closed-loop DBS

Weekly Signal: 50 | The Typing Threshold

Mar 21, 2026

•

14 min read

Weekly Signal: 50 | The Typing Threshold

BCIs Close in on Normal Speed

Ricardo Albornoz

Ethics & Policy

Weekly Signal: 49 | China Wins the BCI Commercial Race

Mar 14, 2026

•

14 min read

Weekly Signal: 49 | China Wins the BCI Commercial Race

The Regulatory Finish Line Just Moved

Ricardo Albornoz

Closed-loop DBS

Weekly Signal: 48 | BCIs Race to First Commercial Products

Mar 8, 2026

•

16 min read

Weekly Signal: 48 | BCIs Race to First Commercial Products

Science Corp. Leads the Pack

Ricardo Albornoz

Closed-loop DBS

Weekly Signal: 47 | Adaptive DBS Gets Its Operating Manual

Mar 1, 2026

•

12 min read

Weekly Signal: 47 | Adaptive DBS Gets Its Operating Manual

Plus: Japan's Stem Cell Gamble

Ricardo Albornoz